News 2011
Press releases
24-11-2011
LEO Foundation announces international dermatology scholarship at royal opening of LEO Pharma Australia
The first ever Australian-Danish dermatology scholarship was announced today at the official opening of LEO Pharma Australia, attended by Their Royal Highnesses the Crown Prince and Crown Princess of Denmark.
23-11-2011
LEO Pharma Research Foundation announces Gold and Silver awards 2011
The LEO Pharma Research Foundation’s Gold and Silver awards 2011 go to Claus Johansen and Charlotte Menné Bonefeld – young researchers with exceptional achievements in dermatology.
21-11-2011
LEO Pharma and Aarhus University clone world's first mini pig for skin disease research
LEO Pharma and Aarhus University have cloned the world’s first transgenic mini pig with a predisposition for psoriasis. The unique animal is expected to transform dermatological research and pave the way for safer and more effective skin treatments in the future.
14-11-2011
New treatment for actinic keratoses submitted in Australia, Brazil and EU
Today, LEO Pharma announced the filing of a marketing authorisation application for Picato® (ingenol mebutate) gel for the treatment of actinic keratoses on the face, scalp or the body, in Australia, Brazil and EU respectively.
29-10-2011
LEO Pharma celebrates World Psoriasis Day
On 29 of October, people suffering from psoriasis from around the whole world unite and call on the public, policy makers and health authorities to understand the burden of psoriasis. Increased awareness about the disease will help improve the lives for patients around the world.
26-10-2011
Danish royal couple visits LEO Pharma Inc. to mark affiliate expansion
HRH the Crown Prince and Princess of Denmark visited LEO Pharma Inc., LEO Pharma’s U.S. affiliate, last week.
05-09-2011
Breakthrough in Diagnosis of Lymphoma of the Skin
Three small microRNA molecules make it possible to distinguish, with 95% accuracy, between lymphoma of the skin and chronic skin diseases such as psoriasis and eczema. The new discovery has just been published in the esteemed journal Blood.
15-07-2011
LEO Pharma A/S and The Scripps Research Institute Enter Collaboration
Global pharmaceutical company LEO Pharma A/S and top biomedical research institute, The Scripps Research Institute have entered a research collaboration.
15-07-2011
LEO Pharma expands the Group Management focusing on the company’s new mission
Last month, LEO Pharma launched a new vision and mission for the company, with increased focus on skin diseases. The objective is to help people with skin diseases around the world.
06-06-2011
Four Phase 3 Efficacy and Safety Studies of Ingenol Mebutate, an Investigational Treatment for Actinic Keratosis, Presented at World Congress of Dermatology
Ingenol mebutate is an investigational two-to-three day topical treatment for precancerous skin disease
28-03-2011
Two new board members to strengthen LEO Pharma’s international growth strategy
LEO Pharma is appointing two new, external members to its board of directors. The aim is to bolster the board with complementary experience in international business development and to maintain momentum for LEO Pharma's growth plans.
28-03-2011
Double-digit growth in annual financial statements 2010 from LEO Pharma
2010 was the first full financial year following the launch of an ambitious growth strategy in October 2009 targeting double-digit sales growth through expansion into new markets, and extension of the product portfolio and the workforce. LEO Pharma met all of its targets for 2010.
07-03-2011
LEO Pharma supports BioBusiness and Innovation Program
On February 25, team “Zyntac” became the first group of students to receive The LEO Pharma Prize, an honour awarded for the excellent business plan they submitted to the BioBusiness & Innovation Program (BBIP) in Denmark.
01-03-2011
New media helps manage psoriasis
In January this year, LEO Pharma Ireland announced two important initiatives aimed to help psoriasis sufferers manage on a daily basis
